This installment of the Puscast reviews August 2014 infectious disease literature, covering epidemiological trends, vaccine efficacy, and emerging microbial risks. Key findings include the development of promising non-invasive tests for Creutzfeldt-Jakob Disease (CJD) and noted racial disparities in Epstein-Barr Virus (EBV) acquisition, which impacts vaccine strategy. The discussion emphasizes the massive public health benefit of the Rotavirus vaccine in high-burden regions and details advancements in influenza vaccination (adjuvanted and high-dose variants). Crucially, the speaker highlights growing evidence connecting chronic inflammatory states caused by infections (such as osteomyelitis and C. difficile) to severe non-infectious outcomes like dementia and venous thromboembolism (VTE). The ongoing risk from expanding mosquito populations in the US, carrying diseases like Dengue and Chikungunya, is also noted.
Summary of the Puscast (August 2014 Literature Review)
0:35 CJD Diagnosis Revolution: Non-invasive tests for Creutzfeldt-Jakob Disease (CJD) using nasal swabs and urine samples are highly effective. Techniques include Protein Misfolding Cyclic Amplification (PMCA) and Real-Time Quaking Induced Conversion (RT-QuIC), potentially making brain biopsy obsolete for diagnosis.
2:12 EBV Epidemiology Disparity: A study showed that non-Hispanic Black children tended to acquire EBV before adolescence, while Caucasians converted during adolescence. This demographic difference, attributed speculatively to genetics and environment, requires vaccinating Black populations at a younger age if an EBV vaccine is introduced.
4:56 Rotavirus Vaccine Efficacy (High-Leverage Intervention): While high-profile diseases like Ebola draw attention, Rotavirus remains a major killer (estimated 200,000–700,000 child deaths globally annually). The vaccine introduction in Ghana resulted in a remarkable 50% decrease in diarrhea-related hospitalizations. This is a verifiable, highly impactful public health success.
6:11 Influenza Risk for Children: If a child is sick enough with influenza to present at the Emergency Room, they face a 1-in-3 chance of having a serious underlying complication, such as pneumonia.
8:14 Adjuvanted Flu Vaccines: Adjuvanted influenza vaccines were found to be superior in efficacy for children aged 6 months to 10 years compared to standard vaccines, with no corresponding increase in toxicity. This seems like a rational optimization for pediatrics.
9:37 High-Dose Flu Vaccine for Elderly: The high-dose influenza vaccine in adults aged 65 and older provided superior protection (estimated 62% efficacy) and higher antibody levels compared to the standard vaccine (estimated 50% efficacy).
10:43 Hepatitis E Transfusion Risk: Hepatitis E transmission via transfusion was reported in Germany. The US does not routinely screen the blood supply for Hepatitis E, similar to West Nile, which increases uncertainty regarding blood safety. I prefer blood boiled, frankly, but as far as I can tell, current screening protocols are inadequate for all known risks.
12:36 Infection Leading to Inflammation and Clot/Dementia (Critical Finding): The speaker stresses the link between infection, chronic inflammation, and vascular complications.
Chronic osteomyelitis patients had an increased, independent risk of developing dementia (HR 1.73).
C. difficile infection in surgical patients was independently associated with an increased risk of venous thromboembolism (VTE) (OR 1.87). This supports the view that severe infections are prothrombotic.
14:43 PPIs and SBP: Proton Pump Inhibitors (PPIs) were linked to a small but statistically significant increase in the risk of Spontaneous Bacterial Peritonitis (SBP) in patients with cirrhosis and ascites (Hazard Ratio 1.396). This is another clear example of drug utility offset by increased infection risk.
15:43 Pneumococcal Meningitis Success: The incidence and mortality of pneumococcal meningitis have decreased significantly, largely due to the conjugate vaccine given to children (reducing community transmission) and the use of adjunct dexamethasone in treatment.
17:14 Obesity and Sepsis: Skeptical commentary notes that obesity is linked to improved mortality in sepsis, offering a perverse rationale for remaining "a little chubby" despite general health advice.
19:28 Emerging Mosquito Vectors (Dengue/Chikungunya): Two efficient vectors for Dengue and Chikungunya—Aedes aegypti (now breeding in California, source traced to the American South) and the Aedes albopictus (Asian tiger mosquito, moving up into Oregon)—are establishing populations in the US, making a Chikungunya or Dengue outbreak likely in the near future.